Skip to main content
Screener/Healthcare/Drug Manufacturers - General

OGN — Organon & Co.

NYSE
$13.29+0.03 (+0.23%)
Mid CapUnder $20HealthcareHigh ROELow Beta
$5.69
$13.39
$13.25
$13.32
EPS (TTM)$0.71
P/E Ratio18.71
Dividend Yield0.91%
Market Cap$2.30B
Volume7.80M
Prev Close$13.25
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$1.5B-$205.0M$-0.7950.4%-13.6%
Q3 '25$1.6B$160.0M$0.6153.5%10.0%
Q2 '25$1.6B$145.0M$0.5654.8%9.1%
Q1 '25$1.5B$87.0M$0.3355.6%5.8%
Q4 '24$1.6B$109.0M$0.4256.3%6.8%
Q3 '24$1.6B$359.0M$1.3858.3%22.7%
Q2 '24$1.6B$195.0M$0.7558.4%12.1%
Q1 '24$1.6B$201.0M$0.7859.0%12.4%
Get Your Daily Market Recap